|
1.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 -  10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
2.
|
|
10 p, 1.3 MB |
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs) : A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Jessop, Helen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Farge, Dominique (McGill University) ;
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Alexander, Tobias (Charité - Universitätsmedizin Berlin) ;
Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sharrack, Basil (University of Sheffield) ;
Greco, Raffaella (San Raffaele Scientific Institute) ;
Wulffraat, Nico (Wilhelmina Kinderziekenhuis) ;
Moore, John (St Vincent's Hospital (Sydney)) ;
Kazmi, Majid (King's College Hospital NHS Foundation Trust) ;
Badoglio, Manuela (EBMT Paris study office) ;
Adams, Geert (EBMT Executive Office) ;
Verhoeven, Bregje (EBMT Executive Office) ;
Murray, John (Christie Hospital NHS Foundation Trust) ;
Snowden, John A (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
Over the last 20 years, haematopoietic stem cell transplantation (HSCT) has been used to treat patients with severe autoimmune and inflammatory diseases whose response to standard treatment options has been limited, resulting in a poor long-term prognosis in terms of survival or disability. [...]
2019 - 10.1038/s41409-019-0430-7
Bone marrow transplantation, Vol. 54 Núm. 7 (january 2019) , p. 933-942
|
|
|
3.
|
|
24 p, 2.3 MB |
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
/
Sharrack, Basil (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ;
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Alexander, Tobias (Charité - Universitätsmedizin Berlin) ;
Badoglio, Manuela (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ;
Burman, Joachim (Department of Neuroscience. Uppsala University) ;
Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ;
Greco, Raffaella (IRCCS San Raffaele Scientific Institute (Milà, Itàlia). Hematology and Bone Marrow Transplantation Unit) ;
Jessop, Helen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Kazmi, Majid (King's College Hospital NHS Foundation Trust) ;
Kirgizov, Kirill Igorevich (N.N. Blokhin National Medical Center of Oncology. Institute of Pediatric Oncology and Hematology) ;
Labopin, Myriam (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ;
Mancardi, Giovanni Luigi (University of Genova and Clinical Scientific Institutes Maugeri. Department of Neuroscience) ;
Martin, Roland (University Hospital Zurich (Suïssa)) ;
Moore, John (St. Vincent's Health Network. Haematology Department.) ;
Muraro, Paolo Antonio (Imperial College London) ;
Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sormani, Maria Pia (IRCCS Ospedale Policlinico San Martino) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Snowden, John A (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
McGrath, Eoin (EBMT Executive Office) ;
Bambi, Franco (Ospedale Pediatrico. Azienda Ospedaliero Universitaria Meyer (A.O.U. Meyer)) ;
Sanchez-Guijo, Fermin (Instituto de Investigación Biomédica de Salamanca) ;
Worel, Nina (Blood Group Serology and Transfusion Medicine. Medical University of Vienna) ;
Abinun, Mario (Great North Children's Hospital. Institute of Cellular Medicine. Newcastle University) ;
Arnold, Renate (Charité - Universitätsmedizin Berlin) ;
Brierley, Charlotte (Oxford University Hospitals NHS Foundation Trust) ;
Castilla-Llorente, Cristina (Unité de transplantation des cellules souches. Département d'Hématologie Gustave Roussy) ;
Cooper, Nichola (Hammersmith Hospital (Londres)) ;
Daikeler, Thomas D. (University Hospital Basel (Basilea, Suïssa)) ;
del Papa, Nicoletta (Ospedale Gaetano Pini. Department of Rheumatology) ;
Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ;
Finke, Jürgen M. (Department of Medicine-Hematology and Oncology. University of Freiburg) ;
Hagglund, Hans G. (Department of Hematology. Uppsala University Hospital) ;
Henes, Jörg Christoph (University Hospital of Tübingen (Alemanya)) ;
Hiepe, Falk (Charité - Universitätsmedizin Berlin) ;
Kiely, David G. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Marjanovic, Z. (Department of Haematology. Saint Antoine Hospital) ;
Martin, Roland (Neuroimmunology and MS Research. Neurology Clinic. University Hospital) ;
Martin, Thierry (Department of Clinical Immunology. National Referral Center for Autoimmune Diseases. Strasbourg University Hospital) ;
Ma, D. (Haematology Department. St. Vincent's Health Network) ;
Moore, J. (Haematology Department. St. Vincent's Health Network) ;
Miller, P. (Anthony Nolan Research Institute) ;
Muraro, P. (Imperial College London) ;
Oliveira, M. C. (Division of Clinical Immunology. Ribeirão Preto Medical School. University of São Paulo) ;
Polushin, A. (Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology. Hematology and Transplantation First State Pavlov Medical University of Saint Petersburg) ;
Onida, F. (Haematology-BMT Centre. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Università degli Studi di Milano) ;
Simoes, B. (Division of Hematology. Ribeirão Preto Medical School. University of São Paulo) ;
Puyade, M. (Centre Hospitalier Universitaire de Poitiers) ;
Resnick, I. (University Hospital St. Marina) ;
Rovira Argelagués, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Saccardi, R. (Careggi University Hospital (Florència, Itàlia)) ;
Saif, M. (Department of Clinical Haematology. Manchester Royal Infirmary) ;
Sakellari, Ioanna (Bone Marrow Transplantation Unit. George Papanicolaou General Hospital) ;
Sharrack, B. (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ;
Snarski, E. (Department of Hematology. Oncology and Internal Medicine. Medical University of Warsaw) ;
Scherer, H. U. (Department of Rheumatology. Leiden University Medical Centre) ;
Sossa, C. (Division of Hematology and Hematopoietic Stem Cell Transplantation. Hematology and Stem Cell Transplantation Unit. Clinica FOSCAL) ;
de Vries-Bouwstra, J. (Department of Rheumatology. Leiden University Medical Centre) ;
Wulffraat, N. (Divisie Kinderen. Cluster Immunologie. Reumatologie. Hematologie en Infectiologie. Wilhelmina Kinderziekenhuis) ;
Zaccara, E. (Osp. G. Pini. Department of Rheumatology) ;
Universitat Autònoma de Barcelona
These updated EBMT guidelines review the clinical evidence, registry activity and mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple sclerosis (MS) and other immune-mediated neurological diseases and provide recommendations for patient selection, transplant technique, follow-up and future development. [...]
2020 - 10.1038/s41409-019-0684-0
Bone marrow transplantation, Vol. 55 Núm. 2 (january 2020) , p. 283-306
|
|
|
4.
|
|
42 p, 717.0 KB |
Biodegradation activity of eight organic substrates : a correlation study of different test methods
/
Evangelous, Alexandro (Democritus University of Thrace. Department of Environmental Engineering) ;
Calabrò, Paolo S. (Università degli Studi Mediterranea) ;
Greco, Rosa (Università degli Studi Mediterranea) ;
Sanchez, Antoni (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Komilis, Dimitrios (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental)
The biological activity of eight organic substrates was assessed using different techniques under aerobic and anaerobic environments at different scales. The used substrates included simulated fresh to actual stabilized composts. [...]
2016 - 10.1007/s12649-016-9532-2
Waste and biomass valorization, Vol. 7, issue 5 (Oct. 2016) p. 1067-1080
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
